These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1551485)

  • 1. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle.
    Cryer PE
    Diabetes; 1992 Mar; 41(3):255-60. PubMed ID: 1551485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia unawareness in IDDM.
    Cryer PE
    Diabetes Care; 1993 Dec; 16 Suppl 3():40-7. PubMed ID: 8299477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM.
    Cryer PE
    Diabetes; 1994 Nov; 43(11):1378-89. PubMed ID: 7926315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
    Dagogo-Jack SE; Craft S; Cryer PE
    J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemia-induced autonomic failure in insulin-dependent diabetes mellitus.
    Cryer PE
    Proc Assoc Am Physicians; 1995 Apr; 107(1):67-70. PubMed ID: 8630745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy.
    Hoeldtke RD; Boden G
    Ann Intern Med; 1994 Mar; 120(6):512-7. PubMed ID: 8311375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes.
    Cryer PE
    Diabetes; 2005 Dec; 54(12):3592-601. PubMed ID: 16306382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
    Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
    Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemia in diabetes.
    Cryer PE; Davis SN; Shamoon H
    Diabetes Care; 2003 Jun; 26(6):1902-12. PubMed ID: 12766131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemia risk reduction in type 1 diabetes.
    Cryer PE
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S412-23. PubMed ID: 11460588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
    Dagogo-Jack S; Rattarasarn C; Cryer PE
    Diabetes; 1994 Dec; 43(12):1426-34. PubMed ID: 7958494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type I (insulin dependent) diabetes mellitus.
    Cryer PE
    Horm Metab Res; 1997 Mar; 29(3):92-6. PubMed ID: 9137976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Kennedy FP; Bolli GB; Go VL; Cryer PE; Gerich JE
    J Clin Endocrinol Metab; 1987 Mar; 64(3):602-8. PubMed ID: 3818892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
    Meyer C; Grossmann R; Mitrakou A; Mahler R; Veneman T; Gerich J; Bretzel RG
    Diabetes Care; 1998 Nov; 21(11):1960-6. PubMed ID: 9802751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased sympathochromaffin activity in IDDM.
    Cryer PE
    Diabetes; 1989 Apr; 38(4):405-9. PubMed ID: 2647548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
    Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
    Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia in diabetes: pathophysiological mechanisms and diurnal variation.
    Cryer PE
    Prog Brain Res; 2006; 153():361-5. PubMed ID: 16876586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.
    Bottini P; Boschetti E; Pampanelli S; Ciofetta M; Del Sindaco P; Scionti L; Brunetti P; Bolli GB
    Diabetes; 1997 May; 46(5):814-23. PubMed ID: 9133549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia-associated autonomic failure in diabetes.
    Cryer PE
    Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1115-21. PubMed ID: 11701423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control.
    Clarke WL; Gonder-Frederick LA; Richards FE; Cryer PE
    Diabetes; 1991 Jun; 40(6):680-5. PubMed ID: 2040384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.